Sodium intake, health implications, and the role of population-level strategies.

cardiovascular disease global health health outcomes policy population-level public health salt sodium sodium reduction

Journal

Nutrition reviews
ISSN: 1753-4887
Titre abrégé: Nutr Rev
Pays: United States
ID NLM: 0376405

Informations de publication

Date de publication:
11 02 2021
Historique:
pubmed: 6 7 2020
medline: 20 4 2021
entrez: 5 7 2020
Statut: ppublish

Résumé

Evidence to date suggests that high sodium intake affects health adversely, yet the role of a population-level strategy to reduce sodium intake is often contested. This review focuses on current available evidence on regional sodium intake levels, health implications of sodium intake, and population-level strategies implemented worldwide. The limitations in evidence, the difficulties in implementing population-wide strategies to reduce sodium intake, and the need for such strategies are critically reviewed. Evidence clearly shows that sodium has an adverse effect on blood pressure, cardiovascular disease, and mortality. However, whether reduced sodium intake benefits all individuals or only hypertensive individuals is still unclear. Methodological issues and publication bias in current evidence are other matters of concern in sodium-related research. While it is essential to continue working toward the World Health Organization's target of 30% reduction in sodium intake, due consideration should be given to improving the quality of research, reducing bias in publications, and reviewing evidence more critically.

Identifiants

pubmed: 32620957
pii: 5867227
doi: 10.1093/nutrit/nuaa042
doi:

Substances chimiques

Sodium, Dietary 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

351-359

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Ghadeer S Aljuraiban (GS)

Department of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Arun Pulikkottil Jose (AP)

Centre for Chronic Conditions and Injuries, Public Health Foundation of India, Gurugram, Haryana, India.

Priti Gupta (P)

Centre for Chronic Disease Control, New Delhi, India.

Krithiga Shridhar (K)

Centre for Chronic Conditions and Injuries, Public Health Foundation of India, Gurugram, Haryana, India.

Dorairaj Prabhakaran (D)

Centre for Chronic Conditions and Injuries, Public Health Foundation of India, Gurugram, Haryana, India.
London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH